BNP Paribas Financial Markets’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
HP
FIM
FPF
IA
MAM
BNP Paribas Financial Markets's OSIR Position: Q1 2017 in Review
BNP Paribas Financial Markets sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 1,153 shares — an estimated $5.66K sold.
BNP Paribas Financial Markets first reported a position in OSIR in Q4 2013 and held it in 12 quarters. The position peaked at $76.9K in Q3 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.
- BNP Paribas Financial Markets reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,153 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $5.66K.
- BNP Paribas Financial Markets first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 12 quarters.
- BNP Paribas Financial Markets's Osiris Therapeutics, Inc. Common Stock position peaked at $76.9K in Q3 2015.
- 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2017, filed 3 May 2017.